Do you want to read an article? Please log in or register.
Higher-Dose Infliximab Induction Achieves Better Maintenance Trough Levels in a National Pediatric IBD Cohort-A Retrospective Study
Inflammatory Bowel Disease
Related content
Inflammatory Bowel Disease
Real-World Experience with Upadacitinib for Pediatric Acute Severe Ulcerative Colitis: An International Multicenter Retrospective Study from the Pediatric IBD Porto Group of ESPGHAN
Inflamm Bowel Dis
Yerushalmy-Feler A, Spencer EA, Bergstein S, Mitrova K, Hradsky O, Bramuzzo M, Wlazlo M, Olbjørn C, Rungoe C, Weil N, Turner D, Cohen S
doi: 10.1093/ibd/izaf166
Inflammatory Bowel Disease
Long-term disease course of ulcerative colitis in a prospective European population-based inception cohort - an Epi-IBD cohort study
J Crohns Colitis
Wewer MD, Lophaven S, Lakatos PL, Gonczi L, Salupere R, Kievit HAL, Nielsen KR, Midjord J, Domislovic V, Krznarić Ž, Pedersen N, Kjeldsen J, Halfvarson J, Sebastian S, Goldis A, Arebi N, Oksanen P, Neumann A, Andersen V, Katsanos KH, Koukoudis A, Turcan S, Ellul P, Kupcinskas J, Kiudelis G, Fumery M, Kaimakliotis IP, D'Inca R, Lombardini S, Hernandez V, Fernandez A, Langholz E, Munkholm P, Burisch J, Epi-IBD-group
doi: 10.1093/ecco-jcc/jjaf089
Gastrointestinal Cancer
Clinical and demographic analysis of patients with colorectal cancer screened at a reference hospital in Southern Brazil: comparative study based on age (Retrospective cohort study)
BMC Gastroenterol
Al-Alam OCM, Alves RJV, Fae AL, Cardoso CN, Lava JR, Castro JP, Signori J, Claudino LG, Wandscheer TBC, Villarinho VV, Yao APMS, Bica CG
doi: 10.1186/s12876-025-03607-6
Inflammatory Bowel Disease
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
Lancet Gastroenterol Hepatol
Choy MC, Li Wai Suen CFD, Con D, Boyd K, Pena R, Burrell K, Rosella O, Proud D, Brouwer R, Gorelik A, Liew D, Connell WR, Wright EK, Taylor KM, Pudipeddi A, Sawers M, Christensen B, Ng W, Begun J, Radford-Smith G, Garg M, Martin N, van Langenberg DR, Ding NS, Beswick L, Leong RW, Sparrow MP, De Cruz P
doi: 10.1016/S2468-1253(24)00200-0
RECOMMENDED
Inflammatory Bowel Disease
Janus kinase (JAK) inhibitor-induced acne in inflammatory bowel disease - an international, multicenter, retrospective cohort study
★ 1
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Clin Gastroenterol Hepatol
Honap S, Temido MJ, Shakweh E, Badrulhisham F, Shields N, Mehta S, McBride J, Uzzan M, Lukáš M, Fumery M, Nogami A, Kobayashi T, Nancey S, Neves JC, Mendes JM, Wegener BA, Bergereau E, Fernandes R, Kuriakose Kuzhiyanjal AJ, Vieujean S, Spencer A, Baillie S, Estevinho MM, Simão I, O'Neill C, Gututui M, Thompson E, Jama A, Chai N, Pavlidis P, D'Amico F, Limdi J, Magro F, Sebastian S, Digby-Bell J, Parkes GC, Din S, Hart A, Peyrin-Biroulet L, JAKne International Study Group
doi: 10.1016/j.cgh.2025.04.031
Inflammatory Bowel Disease
Maintenance treatment with vedolizumab in paediatric inflammatory bowel disease (VEDOKIDS): 54-week outcomes of a multicentre, prospective, cohort study
Lancet Gastroenterol Hepatol
Atia O, Shavit-Brunschwig Z, Lev-Tzion R, Stein R, Broide E, Urlep D, Hyams J, Weiss B, Aloi M, Assa A, Gerasimidis K, Nichols B, Russell RK, Turner D
doi: 10.1016/S2468-1253(24)00319-4
Hepatology
Long-term mortality and extrahepatic outcomes in 1,096 children with MASLD: A retrospective cohort study
Hepatology
Schwimmer JB, Thai NQN, Noon SL, Ugalde-Nicalo P, Anderson SR, Chun LF, David RS, Goyal NP, Newton KP, Hansen EG, Lin B, Shapiro WL, Wang A, Yu EL, Behling CA
doi: 10.1097/HEP.0000000000001357
Inflammatory Bowel Disease
Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicentre retrospective cohort study
J Crohns Colitis
Noviello D, Chaparro M, Viganò C, Blesl A, Barberio B, Yanai H, Orlando A, Ferreiro-Iglesias R, Bezzio C, Zilli A, Molnár T, Gheorghe C, Conforti F, Innocenti T, Saibeni S, Bossuyt P, Oliveira R, Carvalhas Gabrielli AM, Losco A, Vieujean S, Tettoni E, Pirola L, Calderone S, Kornowski Cohen M, Dragoni G, Rath T, Barreiro-de Acosta M, Savarino EV, Gisbert JP, Vecchi M, Atreya R, Caprioli F
doi: 10.1093/ecco-jcc/jjaf056
Hepatology
Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study
Hepatology
Moeckli B, Wassmer CH, El Hajji S, Kumar R, Rodrigues Ribeiro J, Tabrizian P, Feng H, Schnickel G, Kulkarni AV, Allaire M, Asthana S, Karvellas CJ, Meeberg G, Wei L, Chouik Y, Kumar P, Gartrell R, Martinez M, Kang E, Sogbe M, Sangro B, Schwacha-Eipper B, Schmiderer A, Krendl FJ, Goossens N, Lacotte S, Compagnon P, Toso C
doi: 10.1097/HEP.0000000000001289